Vitruvia Medical Valuation

Is 991 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 991 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 991's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 991's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 991?

Key metric: As 991 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 991. This is calculated by dividing 991's market cap by their current revenue.
What is 991's PS Ratio?
PS Ratio0.9x
Sales€1.76m
Market Cap€1.62m

Price to Sales Ratio vs Peers

How does 991's PS Ratio compare to its peers?

The above table shows the PS ratio for 991 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.8x
ECX Epigenomics
9.3xn/a€1.3m
BPXA Bellicum Pharmaceuticals
0.5xn/a€772.4k
ATANA Attana
1.4xn/aSEK 7.8m
SBH Sangui Biotech International
3.8xn/a€419.8k
991 Vitruvia Medical
0.9xn/a€1.6m

Price-To-Sales vs Peers: 991 is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (3.7x).


Price to Sales Ratio vs Industry

How does 991's PS Ratio compare vs other companies in the European Life Sciences Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
991 0.9xIndustry Avg. 4.3xNo. of Companies9PS03.67.210.814.418+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 991 is good value based on its Price-To-Sales Ratio (0.9x) compared to the European Life Sciences industry average (4.5x).


Price to Sales Ratio vs Fair Ratio

What is 991's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

991 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 991's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies